
West Pharmaceutical Services (WST), Cohen & Steers Tax-advantaged Preferred Securities (PTA), and Home BancShares (HOMB) are scheduled to trade ex-dividend on November 12, 2025, for their respective upcoming payments of $0.22 quarterly, $0.134 monthly, and $0.21 quarterly. This will result in an expected price adjustment of 0.08% lower for WST, 0.67% lower for PTA, and 0.76% lower for HOMB, with estimated annualized yields of 0.32%, 8.09%, and 3.06% respectively. In Monday trading, WST shares were down 1.6%, while PTA was up 0.1% and HOMB gained 1.4%.
West Pharmaceutical Services (WST), Cohen & Steers Tax-advantaged Preferred Securities (PTA), and Home BancShares (HOMB) are scheduled to trade ex-dividend on November 12, 2025, for their respective upcoming dividends of $0.22 quarterly, $0.134 monthly, and $0.21 quarterly. These events are expected to result in immediate price adjustments of approximately 0.08% lower for WST, 0.67% lower for PTA, and 0.76% lower for HOMB, all else being equal. The estimated annualized yields, assuming dividend continuity, are 0.32% for WST, a notable 8.09% for PTA, and 3.06% for HOMB. The article highlights that dividend stability, influenced by company profits, is a key factor for investors to consider when evaluating the likelihood of these yields persisting over time. In Monday's trading, WST shares were down 1.6%, exceeding its expected ex-dividend adjustment, while PTA gained 0.1% and HOMB rose 1.4%. This indicates that current price action for PTA and HOMB is positively influenced beyond the upcoming dividend, contrasting with WST's negative sentiment and underperformance relative to its expected ex-dividend impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.05
Ticker Sentiment